CPS Fluidics

Executive Summary

CPS Fluidics is a US-based contract manufacturer specializing in custom microfluidic systems and flow cell technologies for life sciences, diagnostics, and medical device applications. Founded in 2013 and headquartered in Nashville, the company offers end-to-end services from prototyping to commercial-scale manufacturing. Its core value proposition lies in reducing cost, time, and risk for clients through collaborative engineering and a flexible, ISO-certified production process. By serving as an outsourced partner, CPS Fluidics enables customers to accelerate product development without investing in specialized infrastructure, positioning itself as a critical enabler in the rapidly growing microfluidics market. The microfluidics contract manufacturing market is expected to expand significantly, driven by demand for point-of-care diagnostics, lab-on-a-chip devices, and personalized medicine. CPS Fluidics benefits from its early entry, established ISO certification, and focus on custom solutions, which differentiate it from larger, more standardized competitors. However, as a private company with no disclosed funding or revenue, its growth trajectory depends on securing large-scale contracts and expanding capacity. The company's ability to maintain quality, flexibility, and customer relationships will be key to capturing market share in a fragmented industry.

Upcoming Catalysts (preview)

• Q4 2026ISO 13485:2016 Recertification95% success
• H2 2026Expansion of Cleanroom Manufacturing Capacity70% success
• TBDStrategic Partnership with Top-Tier Diagnostics Company35% success